Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial
Open Access
- 27 May 2022
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 33 (9), 950-958
- https://doi.org/10.1016/j.annonc.2022.05.007
Abstract
No abstract availableFunding Information
- AstraZeneca
- Decipher Biosciences
- Astellas Pharma US
- Veracyte
This publication has 17 references indexed in Scilit:
- Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019Journal of Urology, 2019
- Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).Journal of Clinical Oncology, 2018
- Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IMPACT studyCancer, 2017
- Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical ProstatectomyJournal of Clinical Oncology, 2016
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenEuropean Urology, 2016
- Use of Archived Specimens in Evaluation of Prognostic and Predictive BiomarkersJNCI Journal of the National Cancer Institute, 2009
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study DesignJNCI Journal of the National Cancer Institute, 2008
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988